Low-molecular-weight heparins block the formation of new blood vessels and prevent tumor growth, according to the results of a study. Angiogenesis — the development of new blood vessels — fuels cancer cell reproduction. The use of low-molecular-weight heparins (LMWHs) has been shown to extend survival in cancer patients by reducing the clotting action of blood. However, the mechanism is unclear.